Metrics as of 10/16/2026, 08:40 AM (Berlin time), refresh in progress.
Scancell Holdings Stock
Scancell Holdings plc
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United Kingdom
- CEO
- Phillip John L'Huillier
- Employees
- 60
- Market cap
- £113 M
- IPO
- 12/02/2010
Scancell Holdings plc is a clinical-stage biopharmaceutical firm focused on discovering and developing innovative vaccine and antibody treatments. Its mission is to address significant unmet medical needs in both cancer and infectious diseases. The company's pipeline features several promising candidates, including…
Scancell Holdings stock: price history
1D
+0.0%
1W
-0.5%
1M
-5.1%
6M
-29.4%
YTD
-5.6%
1Y
-4.1%
2Y
-29.4%
5Y
-57.0%
10Y
-41.0%
Next earnings date
Next earnings date
04/02/2027 (in 110 days)
Volatility around earnings
~19% weaker price swings than usual
Ask the agents about Scancell Holdings
Scancell Holdings stock metrics
P/E
-5.44
P/B
-5.01
EV/EBITDA
-9.14
RETURN ON EQUITY
62.6%
NET MARGIN
0.0%
DEBT/EQUITY
-0.88
DIVIDEND YIELD
0.0%
AS OF
30/04/2026
Free float & liquidity
FREE FLOAT
97.5%
FLOAT SHARES
1,181,695,139
AVG. DAILY VOLUME (30D)
1,989,255
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Scancell Holdings stock
What does Scancell Holdings do?
Scancell Holdings plc is a company in the Healthcare sector, Biotechnology industry, headquartered in United Kingdom.
The CEO is Phillip John L'Huillier, the company employs around 60 people.
The IPO was on 12/02/2010; the stock trades on LSE under the ticker SCLP.L.
When does Scancell Holdings report next?
The next earnings date is 04/02/2027.
Around past earnings, price swings were roughly -19% stronger than usual.
Does Scancell Holdings pay a dividend?
No, Scancell Holdings currently does not pay a dividend.
Which stocks are comparable to Scancell Holdings?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
How can I get Scancell Holdings stock analyzed?
Clicking "Analyze stock" lets five strategies assess Scancell Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.